xista science ventures

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, specializing in the development of a machine platform for the large-scale, industrial manufacturing of personalized cell therapies aimed at treating cancer. The company employs advanced semiconductor technology and microfluidic processing to facilitate real-time process control and manipulation at the cellular level. This innovative approach enables a fully automated and modular manufacturing system, enhancing the efficiency and safety of cell therapies while making them more cost-effective for patients. Based in Hinterstoder, Austria, Sarcura is poised to transform manufacturing paradigms in the field of patient-specific cancer treatment.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Ribbon Biolabs GmbH is a Vienna, Austria-based company founded in 2018 that specializes in the synthesis of long DNA molecules. The company aims to advance molecular biology by developing innovative methods for DNA synthesis, enabling the creation and exploration of genetic solutions through high-throughput synthesis of unprecedentedly long DNA sequences. Ribbon Biolabs' technology supports a wide range of applications, including genome construction, high-throughput libraries, DNA-based data storage and computing, and the development of DNA nanotechnologies. This allows researchers and companies to work with extensive DNA libraries without economic or time constraints.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, specializing in the development of a machine platform for the large-scale, industrial manufacturing of personalized cell therapies aimed at treating cancer. The company employs advanced semiconductor technology and microfluidic processing to facilitate real-time process control and manipulation at the cellular level. This innovative approach enables a fully automated and modular manufacturing system, enhancing the efficiency and safety of cell therapies while making them more cost-effective for patients. Based in Hinterstoder, Austria, Sarcura is poised to transform manufacturing paradigms in the field of patient-specific cancer treatment.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

Ribbon Biolabs GmbH is a Vienna, Austria-based company founded in 2018 that specializes in the synthesis of long DNA molecules. The company aims to advance molecular biology by developing innovative methods for DNA synthesis, enabling the creation and exploration of genetic solutions through high-throughput synthesis of unprecedentedly long DNA sequences. Ribbon Biolabs' technology supports a wide range of applications, including genome construction, high-throughput libraries, DNA-based data storage and computing, and the development of DNA nanotechnologies. This allows researchers and companies to work with extensive DNA libraries without economic or time constraints.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.